New neurohormonal antagonists and atrial natriuretic peptide in the treatment of congestive heart failure.
Abraham
W T
WT
Temple Hoyne Buell Heart Center Research Laboratories, Division of Cardiology, University of Colorado Health Sciences Center, Denver.
D000804:Angiotensin II / Q000037:antagonists & inhibitors; D001127:Arginine Vasopressin / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D009320:Atrial Natriuretic Factor / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D018377:Neurotransmitter Agents / Q000037:antagonists & inhibitors* / Q000627:therapeutic use*; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology; D000092502:Renin Inhibitors
D000804:Angiotensin II; D001127:Arginine Vasopressin; D009320:Atrial Natriuretic Factor; D018377:Neurotransmitter Agents; D000092502:Renin Inhibitors